Williams Stephanie L, Qi Li, Sheng Zong-Mei, Xiao Yongli, Freeman Ashley, Matthews Lex, Legaspi Sharon Fong, Fodor Ervin, Taubenberger Jeffery K
Viral Pathogenesis and Evolution Section, Laboratory of Infectious Disease, National Institutes of Health, National Institute for Allergy and Infectious Diseases, Bethesda, MD, USA.
Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Sci Adv. 2024 Dec 13;10(50):eads5735. doi: 10.1126/sciadv.ads5735.
Zoonotic influenza A virus (IAV) infections pose a substantial threat to global health. The influenza RNA-dependent RNA polymerase (RdRp) comprises the PB2, PB1, and PA proteins. Of the last four pandemic IAVs, three featured avian-origin PB1 genes. Prior research linked these avian PB1 genes to increased viral fitness when reassorted with human IAV genes. This study evaluated chimeric RdRps with PB1 genes from the 1918, 1957, and 1968 pandemic IAVs in a low pathogenic avian influenza (LPAI) virus background to assess polymerase activity and pathogenicity. Substituting in the pandemic PB1 genes reduced polymerase activity, virulence, and altered lung pathology, while the native LPAI PB1 showed the highest pathogenicity and polymerase activity. The native LPAI PB1 virus caused severe pneumonia and high early viral RNA levels, correlating with elevated host cytokine signaling. Increased genetic distance from the LPAI PB1 sequence correlated with reduced polymerase activity, IFN-β expression, viral replication, and pathogenicity.
人畜共患甲型流感病毒(IAV)感染对全球健康构成重大威胁。流感病毒的RNA依赖性RNA聚合酶(RdRp)由PB2、PB1和PA蛋白组成。在过去四次大流行的IAV中,有三次具有禽源PB1基因。先前的研究表明,当这些禽源PB1基因与人类IAV基因重配时,会提高病毒的适应性。本研究评估了在低致病性禽流感(LPAI)病毒背景下,含有1918年、1957年和1968年大流行IAV的PB1基因的嵌合RdRp,以评估聚合酶活性和致病性。替换大流行的PB1基因会降低聚合酶活性、毒力并改变肺部病理,而天然的LPAI PB1表现出最高的致病性和聚合酶活性。天然LPAI PB1病毒可引起严重肺炎和早期高病毒RNA水平,这与宿主细胞因子信号升高相关。与LPAI PB1序列的遗传距离增加与聚合酶活性降低、IFN-β表达降低、病毒复制减少和致病性降低相关。